Events

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Natalie Newell. Why You Should Attend Behavioural science, and in particular the science of patient health behaviours, is the new buzz in pharma’s patient-centric community. Whilst the challenge of non-adherence has been around for as long as medications exist, successful efforts to address the challenge have been scarce. This is primarily due to a lack of knowledge in two areas: W…

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal Why You Should Attend The Content: Business Development in the pharmaceutical industry has become the most significant source of new products for most pharmaceutical companies. It is now conducted throughout every organisation, which requires executives in many disciplines to understand the process. Even executives new in a business development role often have had no formal training. Companies need to have a structured process throughout the organisation to ensure that there is coordination of efforts and alignment of strategy. This course has been writ…

Gain confidence by understanding where and how you, as an MSL, add value to a pharma company – Gain business acumen to propel your tactical planning and implementation to higher productivity levels and with more impact on both external and internal stakeholders – Learn best practices and benefit from exchanging experiences with MSLs from other companies. Why You Should Take This Online Course While the Medical Science Liaison (MSL) function is relatively new in the pharma industry, its role has become even more important during COVID-times, and that will remain so in the future. Therefore, all MSLs absolutely need to acquire critical business acumen competencies as early as possible in their career.   The impact of MSLs is potentially huge because they act at the forefront of the…

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal. Why You Should Attend Valuation is an inherently subjective task which is made even more difficult in the life science industry due its unique challenges: high attrition rates in R&D, long investment cycle, complex technologies and IP situations, etc. Therefore, traditional valuation methods are not suitable. The Content: This course is designed to teach you a systematic approach to producing a valuation which can be used in investment rounds, mergers/acquisitions, licensing deals or strategic developmen…

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught. Why You Should Attend With every major business decision in pharma being based on a sales forecast, it is imperative that you know how to forecast (and challenge forecasts) accurately. Therefore, the focus of this course is on teaching the concepts, techniques and approaches which have been proven to work best for pharmaceuticals.  The Content: Unlike other forecasting courses, this programme teaches a multitude of modelling techniques&…

Grasp the meaning, concepts, terminology, methodologies and research techniques of Real World Evidence (RWE) in the context of optimising Market Access - Know what each stakeholder type expects from RWE, which key data to use and how to develop a successful RWE study – Learn how to incorporate RWE into the product pre-launch process. Why You Should Attend RWE is now a critical area of expertise in pharmaceutical companies, engaging various functions such as HEOR, Medical Affairs, R&D and Commercial. There are many challenges in the process of successfully implementing RWE. Executives participating in this open-enrollment course will contribute much more effectively in the cross-functional organisation that RWE requires. The Content: The course covers the basics required to un…

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan. Why You Should Attend In the last decade, pharmaceutical companies have seen rapid changes in the market environment for their new brand launches. While austerity measures in many countries are increasing local and national hurdles for market access, drug launches are becoming more numerous, smaller, and more competitive. It has never been more important for pharmaceutical companies to crack the art of launching new products. YOU ONLY CAN DO…

The targeted protein degradation field is expanding, gone are the days of simple proof of concept…. We now have LYTACs, AUTACs and ATTECs as well as numerous PROTAC and Molecular Glue companies with millions of dollars worth of investment. C4 netted $182.4 million in IPO, and Nurix and Kymera closed funding with $120 million and $102 million apiece. With several start-ups launching, including Lycia and Amphista therapeutics, investment in this area is booming, and it’s not slowing down. There are currently over 85 degraders being considered at various stages of development, both preclinical and clinical, as well as in discovery. However, key questions are yet to be answered: How will degrader research translate in the clinic? Why are we still struggling with oral bioavailability? How can…

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact. Why You Should Attend The Content: This course not only provides you with an explanation behind concepts, tactics and trends, but more importantly, it discusses the integration of digital in the overall business strategy and marketing plans. The course also examines the perspective of the customer and other stakeholders and uses multiple, real, best-practice cases to bring the theory to life. The Expert: Our experts, Vladimir Rogiers and Jan Keuppens, not only hav…

Virtual Conference: Online Access Only   Sponsored by: CelVivo Chaired by: Stefan Przyborski, Professor of Cell Technology, Durham University 3D Cell Culture is gaining momentum in the pharmaceutical industry, with the global 3D Cell Culture market predicted to surpass a value of $3.2 Billion by 2027. Researchers globally are realising the potential of in vitro applications for drug discovery, predictivity and validation, safety, and toxicity.SMi’s 5th Annual 3D Cell Culture Conference will be covering the application of 3D cell culture to drug development, toxicity testing, and safety assurance. In addition, the conference will look into the newest breakthroughs in Organ Chip technology, 3D Multicellular scaffolding, Microphysiological Systems, and 3D Bioprinting. In recent years tec…

RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy personalised medicines, and treatment of genetic, infectious and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%. Furthermore, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, have triggered a major expansion of the RNA-therapeutics field. The 2021 conference is set to explore the latest developments in RNA delivery agents and RNA-based therapeutics with the latest case studies on advanced mRNA technologies, oligonucleotide delivery, therapeutic applications and future…

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure. Why You Should Attend The Content: Unlike other negotiation courses, this course is specifically tailored to negotiating commercial licensing deals for pharmaceuticals and related products in the Pharma and Biotech sectors. The Expert: Roger Cox is an industry veteran and highly regarded in pharma’s BD&L community. Roger’s profile is unique - his 30 years of licensing experience encompasses both big and small pharma/biotech companies as well as governme…

The 12th Annual Pharma Market Research Conference (February 3-4, 2021, New Jersey) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 10+ years. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives. The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships. Attendees will walk away with invaluable information, integrated connections, and countless business opportunities.

United Kingdom

Managing Your Mental Health & Wellbeing When Working from Home - Issues to Consider During COVID-19 Pandemic - Learn Live1 February 2021 | 3:00pm ‑ 4:30pm | Interactive Online SeminarLearn Live is an interactive online seminar which you watch and participate in from your computer at a set date and time. This live broadcast session will provide you with practical strategies to look after your mental health whilst working from home during the COVID-19 lockdown. The aim of this session is to provide delegates with an introduction to a range of strategies to support themselves (and those around them) who are currently working at home for a long period of time. Mental health first aid trainer Maisie McKenzie will discuss stress, mental health and mental illness, and…

The 4th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. With momentum building for antigen specific immunotherapies, ASIT 2021 will be the only antigen-specific summit offering thought-leading content to drive the field towards a more precise and ethical antigen-specific approach to drug development. This is the industry's definitive antigen specific drug development forum. Across 3 packed days, thought leaders from Novartis, ImCyse, Harvard Medical School, Toleranzia, Toralgen will reveal insight, data, and lessons learned from the last 12 months to enable you to hurdle the roadblocks preventing the d…

R and D and Clinical Processes for the Future: Accurate, Efficient and Cost-Effective The AI-ML: Drug Discovery and Development Summit is the industry's definitive guide to translating the wealth of tech available to successfully implement a working and practically effective drug discovery and development platform. Designed with leading AI experts from R and D and clinical departments across big pharma, biotech, and academia, this year's forum features 3 days of real-world case studies and interactive discussions. As such, the 2020 AI-ML Summit will provide you with a roadmap to augmented R and D and clinical decision making with reduced failure rates, increased speed, and improved margins. This is a critical time for drug developers to make more data-driven decisions, and at the 4th…

Euro Pediatrics and Neonatology Virtual Congress (PedNeo 2021) aims to provide a phase for controlling new-born and infant natality rate, the spread of infectious disease and endorse with the healthy lifestyle for a prolonged disease-free life by helping to ease the complications of children & adolescents with prolonged disorders Join us at Euro Pediatrics and Neonatology Virtual Congress (PedNeo 2021). With the support from Pediatrics Organizations and Societies, Pediatrics Conference will deliver a manifold program focused on pediatric care and emerging child health issues  

Asian Public Mental Health Virtual Congress pertains to Psychiatry and Mental Health Disorders such as anxiety, depression, bipolar, behavioral disorders, post-traumatic, seasonal depression, persistent depressive disorder, stress and understanding the effective diagnosis & treatment to identify and help to facilitate the recovery of someone suffering from psychiatric disorders. Target Audience: Clinical Psychologists Psychopharmacologists Mental Health Professionals Neuropsychiatrists Neurophysiologists Neuropathologists Counselors and Social Workers Healthcare Professionals in the Behavioral Sciences  Conference Central Topics: Neurology and Mental Health Human Resilience Epilepsy and Brain Disorder Addiction and Mental Health Stress, Anxiety and De…